Autopsy report · NCT00414570

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

“Retirement of former Qualified Investigator and lack of resources to complete study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 11 years 3 months before it stopped.
• 11 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Early Phase 1

Sponsor

AHS Cancer Control Alberta

Sponsor type

University, hospital or other

Conditions

Pancreatic Cancer

Interventions

[18]F-FLT PET scan

Participants

11

Sites

1

Countries

Canada

Trials that died the same way

• Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy
  “Investigator Retirement” (79% match in meaning)
• Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy
  “Retirement of the Principal Investigator” (71% match in meaning)
• The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer
  “Principal Investigator retired before study completed.” (70% match in meaning)
• Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)
  “Investigator left institution and did not retain the study” (68% match in meaning)
• Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
  “Original investigator left this institution, replacement investigator retired.” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.